The molecular mechanisms of regulatory T cell immunosuppression
نویسندگان
چکیده
منابع مشابه
The molecular mechanisms of regulatory T cell immunosuppression
Fifty years ago Jacques Miller devised a technique to thymectomize neonatal mice to explore the hypothesis that the thymus played a role in the development of immunity. He found that if thymectomized by day 3 postpartum, the mice would develop normally for the first month, but thereafter they underwent a runting syndrome similar to that observed during Graft vs. Host Disease (GvHD) (Miller, 196...
متن کاملThe Molecular Mechanisms of Regulatory T Cell Immunosuppression
CD4⁺CD25⁺Foxp3⁺ T lymphocytes, known as regulatory T cells or T(regs), have been proposed to be a lineage of professional immune suppressive cells that exclusively counteract the effects of the immunoprotective "helper" and "cytotoxic" lineages of T lymphocytes. Here we discuss new concepts on the mechanisms and functions of T(regs). There are several key points we emphasize: 1. Tregs exert sup...
متن کاملT-cell regulatory mechanisms in specific immunotherapy.
Allergen-specific immunotherapy (SIT) is the only treatment which leads to a lifelong tolerance against previously disease-causing allergens due to restoration of normal immunity against allergens. The description of T-regulatory (Treg) cells being involved in prevention of sensitization to allergens has led to great interest whether they represent a major target for allergen-SIT and whether it...
متن کاملT-cell-receptor-dependent actin regulatory mechanisms.
Following stimulation, T cells undergo marked changes in actin architecture that are required for productive immune responses. T-cell-receptor-dependent reorganization of the actin cytoskeleton is necessary for the formation of the immunological synapse at the T-cell-antigen-presenting-cell contact site and the distal pole complex at the opposite face of the T cell. Convergence of specific sign...
متن کاملLenalidomide overcomes the immunosuppression of regulatory CD8+CD28− T-cells
Although lenalidomide and pomalidomide are well-established treatment options in patients with multiple myeloma, their immune-modulating effects are not fully understood. While CD8+CD28- regulatory T-cells in patients with hematologic disorders display a known immune-escape mechanism, we show that lenalidomide can overcome the immunosuppressive impact of CD8+CD28- T-cells. We analyzed in vitro ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Frontiers in Immunology
سال: 2012
ISSN: 1664-3224
DOI: 10.3389/fimmu.2012.00379